Cargando…
Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612840/ https://www.ncbi.nlm.nih.gov/pubmed/36320826 http://dx.doi.org/10.1016/S2665-9913(22)00256-9 |
_version_ | 1784819853856604160 |
---|---|
author | Kelly, Clive |
author_facet | Kelly, Clive |
author_sort | Kelly, Clive |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9612840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96128402022-10-28 Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease Kelly, Clive Lancet Rheumatol Comment Published by Elsevier Ltd. 2022-11 2022-09-13 /pmc/articles/PMC9612840/ /pubmed/36320826 http://dx.doi.org/10.1016/S2665-9913(22)00256-9 Text en Crown Copyright © 2022 Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Kelly, Clive Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease |
title | Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease |
title_full | Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease |
title_fullStr | Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease |
title_full_unstemmed | Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease |
title_short | Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease |
title_sort | increased risk of severe covid-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612840/ https://www.ncbi.nlm.nih.gov/pubmed/36320826 http://dx.doi.org/10.1016/S2665-9913(22)00256-9 |
work_keys_str_mv | AT kellyclive increasedriskofseverecovid19outcomesinpatientswithrheumatoidarthritisandinterstitiallungdisease |